Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Malisauskas M"'
Autor:
Canis, K. 1, Anzengruber, J. 2, Garenaux, E. 1, Feichtinger, M. 2, Benamara, K. 3, Scheiflinger, F. 3, Savoy, L.‐A. 1, Reipert, B.M. 3, *, Malisauskas, M. 3
Publikováno v:
In Journal of Thrombosis and Haemostasis August 2018 16(8):1592-1603
Autor:
Malisauskas, M.1 mantas.malisauskas@medchem.umu.se, Darinskas, A.2 innovita@innovitaresearch.org, Zamotin, V. V.1, Gharibyan, A.1, Kostanyan, I. A.3 iakost@mail.ibch.ru, Morozova-Roche, L. A.1,4 ludmilla.morozova-roche@medchem.umu.se
Publikováno v:
Biochemistry (00062979). May2006, Vol. 71 Issue 5, p505-512. 8p. 2 Diagrams, 1 Chart, 3 Graphs.
Autor:
Mattis C; 359181AbbVie, Inc., North Chicago, IL, USA., Bratcher N; 359181AbbVie, Inc., North Chicago, IL, USA., Burns M; 33413Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA, USA., Carosino C; 1874Seagen, Inc., Bothell, WA, USA., de Zafra C; 1874Seagen, Inc., Bothell, WA, USA., Fancher RM; 480678Bristol-Myers Squibb, Inc., Princeton, NJ, USA., Georgi K; The healthcare business of Merck KGaA, Darmstadt, Germany., Graff C; 359181AbbVie, Inc., North Chicago, IL, USA., Hukkanen RR; 42372Eisai, Inc., Cambridge, MA, USA., Johnson C; 2793Merck & Co., Inc., Kenilworth, NJ, USA., Lao Y; 480678Bristol-Myers Squibb, Inc., Princeton, NJ, USA.; Eli Lilly and Company, Indianapolis, IN, USA., Lange A; 33413Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA, USA., Lee D; 7412Genentech, Inc., South San Francisco, CA, USA., Lepherd M; 7412Genentech, Inc., South San Francisco, CA, USA., Maguire S; 5545GlaxoSmithKline, Inc., Collegeville, PA, USA., Malisauskas M; The healthcare business of Merck KGaA, Darmstadt, Germany., Manuel M; 13498Takeda, San Diego, CA, USA., Miranda S; 33413Novartis Institutes for Biomedical Research (NIBR), Cambridge, MA, USA., Reed L; 105623Pfizer, Inc., Groton, CT, USA., Santos R; 105623Pfizer, Inc., Groton, CT, USA., Sayers B; 4999Incyte Corporation, Wilmington, DE, USA., Shaw D; Roche Innovation Center Basel, 1529F.Hoffmann-La Roche, Ltd., Basel, Switzerland., Shuster D; 480678Bristol-Myers Squibb, Inc., Princeton, NJ, USA.
Publikováno v:
International journal of toxicology [Int J Toxicol] 2022 Aug; Vol. 41 (4), pp. 291-296. Date of Electronic Publication: 2022 Jun 02.
Autor:
Anzengruber, J. 1, *, Lubich, C. 1, Prenninger, T. 1, Gringeri, A. 2, Scheiflinger, F. 1, Reipert, B.M. 1, Malisauskas, M. 1
Publikováno v:
In Journal of Thrombosis and Haemostasis June 2018 16(6):1176-1181
Autor:
Lotz GP; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany. gregor.lotz@roche.com., Benstein K; Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main, Germany., Bloem K; Biologics Lab, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Buddiger H; Genmab B.V., Uppsalalaan 15, Utrecht, The Netherlands., Calonder C; Novartis Institutes for BioMedical Research, Basel, Switzerland., Elm S; Amgen Research (Munich) GmbH, Munich, Germany., Fernandez E; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Goodman J; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK., Gorovits B; Sana Biotechnology, Inc., MA, Cambridge, USA., Grudzinska-Goebel J; Bayer AG, Drug Metabolism & Pharmacokinetics, Berlin, Germany., Janssen M; SciPot Consultancy, Amsterdam, The Netherlands., Jawa V; Bristol Myers Squibb, Biotherapeutics and Bioanalysis Non-Clinical Development, Princeton, New Jersey, USA., Kramer D; Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main, Germany., Luo L; Regulated BA, Merck & Co., Inc., Kenilworth, New Jersey, USA., Malisauskas M; Merck KGaA, Darmstadt, Germany., Michaut L; Integrated Biologix, Basel, Switzerland., Schäfer M; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Spindeldreher S; Integrated Biologix, Basel, Switzerland., Ullmann M; Fresenius Kabi, Eysins, Switzerland., Nana Weldingh K; Novo Nordisk, Non-clinical & Clinical Assay Sciences, Maaloev, Denmark., Kromminga A; Kromminga Consulting, Hamburg, Germany.; Institute for Immunology, Kiel, Germany., Snoeck V; UCB Biopharma SRL, Translational Biomarkers and Bioanalysis, Braine-l'Alleud, Belgium.
Publikováno v:
The AAPS journal [AAPS J] 2022 May 12; Vol. 24 (3), pp. 68. Date of Electronic Publication: 2022 May 12.
Autor:
Pansieri J; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se., Iashchishyn IA; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se., Fakhouri H; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Univ Lyon F-69100 Villeurbanne France., Ostojić L; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se., Malisauskas M; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se., Musteikyte G; Institute of Biotechnology, Life Sciences Center, Vilnius University Vilnius Lithuania., Smirnovas V; Institute of Biotechnology, Life Sciences Center, Vilnius University Vilnius Lithuania., Schneider MM; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK., Scheidt T; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK., Xu CK; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK., Meisl G; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK., Knowles TPJ; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK.; Cavendish Laboratory, Department of Physics, University of Cambridge JJ Thompson Ave CB3 0HE Cambridge UK., Gazit E; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se.; School of Molecular Cell Biology and Biotechnology, Tel Aviv University Tel Aviv 69978 Israel., Antoine R; Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Univ Lyon F-69100 Villeurbanne France., Morozova-Roche LA; Department of Medical Biochemistry and Biophysics, Umeå University SE-90187 Umeå Sweden ludmilla.morozova-roche@umu.se.
Publikováno v:
Chemical science [Chem Sci] 2020 Jun 17; Vol. 11 (27), pp. 7031-7039. Date of Electronic Publication: 2020 Jun 17.
Autor:
Rhea, Elizabeth M.1,2 meredime@uw.edu, Leclerc, Manon3,4, Yassine, Hussein N.5, Capuano, Ana W.6, Han Tong6, Petyuk, Vladislav A.7, Macauley, Shannon L.8, Fioramonti, Xavier9,10, Carmichael, Owen11, Calon, Frederic3,4,9, Arvanitakis, Zoe6
Publikováno v:
Aging & Disease. Aug2024, Vol. 15 Issue 4, p1688-1725. 38p.
Autor:
Anzengruber J; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria. julia.anzengruber@takeda.com., Feichtinger M; Technical Operations, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Bärnthaler P; Technical Operations, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Haider N; Technical Operations, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Ilas J; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Pruckner N; Technical Operations, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Benamara K; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Scheiflinger F; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Reipert BM; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria., Malisauskas M; Research & Development, Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.
Publikováno v:
Pharmaceutical research [Pharm Res] 2019 Apr 01; Vol. 36 (5), pp. 77. Date of Electronic Publication: 2019 Apr 01.
Autor:
Bunk S; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Ponnuswamy P; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Trbic A; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Malisauskas M; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Anderle H; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Weber A; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Ilas J; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Winkler AM; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Butterweck HA; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Teschner W; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Scheiflinger F; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Hermann C; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria., Reipert BM; Baxalta Innovations GmbH, Shire Pharmaceuticals, Vienna, Austria. Electronic address: birgit.reipert@shire.com.
Publikováno v:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2019 Jan; Vol. 198, pp. 62-70. Date of Electronic Publication: 2018 Oct 31.
Autor:
Wilhelm, K. R., Yanamandra, K., Gruden, M. A., Zamotin, V., Malisauskas, M., Casaite, V., Darinskas, A., Forsgren, L., Morozova-Roche, L. A.
Publikováno v:
European Journal of Neurology; Mar2007, Vol. 14 Issue 3, p327-334, 8p, 1 Black and White Photograph, 1 Chart, 4 Graphs